青光眼治疗的新方向：聚焦于肌纤蛋白的嗅觉介蛋白结构域。 - Suppr | 超能文献

New direction for glaucoma therapeutics: focus on the olfactomedin domain of myocilin.

作者信息

Donegan Rebecca K, Lieberman Raquel L

出版信息

Future Med Chem. 2012 Nov;4(17):2131-4. doi: 10.4155/fmc.12.132.

DOI:10.4155/fmc.12.132

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

New direction for glaucoma therapeutics: focus on the olfactomedin domain of myocilin.青光眼治疗的新方向：聚焦于肌纤蛋白的嗅觉介蛋白结构域。

Future Med Chem. 2012 Nov;4(17):2131-4. doi: 10.4155/fmc.12.132.

2

The stability of myocilin olfactomedin domain variants provides new insight into glaucoma as a protein misfolding disorder.原纤维蛋白细胞黏附分子域变异体的稳定性为青光眼作为一种蛋白质错误折叠疾病提供了新的见解。

Biochemistry. 2011 Jul 5;50(26):5824-33. doi: 10.1021/bi200231x. Epub 2011 Jun 9.

3

The glaucoma-associated olfactomedin domain of myocilin is a novel calcium binding protein.青光眼相关的肌球蛋白嗅素结构域是一种新型的钙结合蛋白。

J Biol Chem. 2012 Dec 21;287(52):43370-7. doi: 10.1074/jbc.M112.408906. Epub 2012 Nov 5.

4

Inefficient processing of an olfactomedin-deficient myocilin mutant: potential physiological relevance to glaucoma.嗅觉介质缺乏的肌纤蛋白突变体的低效加工：与青光眼潜在的生理相关性。

Biochem Biophys Res Commun. 2001 Apr 6;282(3):662-70. doi: 10.1006/bbrc.2001.4624.

5

Progress toward development of a proteostasis drug for myocilin-associated glaucoma.用于治疗与肌纤蛋白相关青光眼的蛋白质稳态药物的研发进展。

Future Med Chem. 2018 Jun 1;10(12):1391-1393. doi: 10.4155/fmc-2018-0073. Epub 2018 May 23.

6

The glaucoma-associated olfactomedin domain of myocilin forms polymorphic fibrils that are constrained by partial unfolding and peptide sequence.原纤维蛋白由肌球蛋白相关的青光眼嗅觉素结构域组成，该结构域通过部分展开和肽序列的限制形成多态性纤维。

J Mol Biol. 2014 Feb 20;426(4):921-35. doi: 10.1016/j.jmb.2013.12.002. Epub 2013 Dec 9.

7

Structural basis for misfolding in myocilin-associated glaucoma.与肌纤蛋白相关青光眼错误折叠的结构基础

Hum Mol Genet. 2015 Apr 15;24(8):2111-24. doi: 10.1093/hmg/ddu730. Epub 2014 Dec 18.

8

Myocilin mutations causing glaucoma inhibit the intracellular endoproteolytic cleavage of myocilin between amino acids Arg226 and Ile227.导致青光眼的肌纤蛋白突变会抑制肌纤蛋白在氨基酸精氨酸226和异亮氨酸227之间的细胞内蛋白水解切割。

J Biol Chem. 2005 Jun 3;280(22):21043-51. doi: 10.1074/jbc.M501340200. Epub 2005 Mar 28.

9

Molecular Insights into Myocilin and Its Glaucoma-Causing Misfolded Olfactomedin Domain Variants.分子洞察肌球蛋白及其导致青光眼的错误折叠嗅觉调节蛋白结构域变体。

Acc Chem Res. 2021 May 4;54(9):2205-2215. doi: 10.1021/acs.accounts.1c00060. Epub 2021 Apr 13.

10

Ligands for glaucoma-associated myocilin discovered by a generic binding assay.通过通用结合测定法发现与青光眼相关的肌球蛋白配体。

ACS Chem Biol. 2014 Feb 21;9(2):517-25. doi: 10.1021/cb4007776. Epub 2013 Dec 9.

引用本文的文献

1

Ligands for glaucoma-associated myocilin discovered by a generic binding assay.通过通用结合测定法发现与青光眼相关的肌球蛋白配体。

ACS Chem Biol. 2014 Feb 21;9(2):517-25. doi: 10.1021/cb4007776. Epub 2013 Dec 9.